Wells Fargo & Company Lixte Biotechnology Holdings, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.51 - $1.89 $0 - $1	1 Added 1.92%	53 $0
Q4 2022 Feb 13, 2023	BUY	$0.48 - $6.0 $0 - $6	1 Added 1.96%	52 $0
Q3 2022 Nov 14, 2022	BUY	$0.12 - $5.9 $0 - $11	2 Added 4.08%	51 $0
Q2 2022 Aug 12, 2022	BUY	$0.12 - $0.35 $2 - $7	22 Added 81.48%	49 $0
Q3 2021 Nov 15, 2021	BUY	$0.52 - $0.85 $5 - $9	11 Added 68.75%	27 $0
Q1 2021 May 13, 2021	BUY	$0.8 - $1.2 $12 - $19	16 New	16 $0

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33.6M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.